Edition:
India

Ion Beam Applications SA (IBAB.BR)

IBAB.BR on Brussels Stock Exchange

23.32EUR
18 Jan 2018
Change (% chg)

€1.82 (+8.47%)
Prev Close
€21.50
Open
€21.58
Day's High
€23.40
Day's Low
€21.32
Volume
311,737
Avg. Vol
116,616
52-wk High
€56.94
52-wk Low
€15.80

Chart for

About

Ion Beam Applications SA (IBA) is a Belgium-based company that develops and markets technologies, pharmaceutical products and tailored solutions for the healthcare sector, with emphasis on cancer diagnosis and therapy. IBA is also active in the sterilization and ionization field. The Company operates through two business... (more)

Overall

Beta: 0.68
Market Cap(Mil.): €836.65
Shares Outstanding(Mil.): 29.88
Dividend: 0.29
Yield (%): 0.73

Financials

Proton therapy firm IBA sees operating loss due to contract delays

Jan 5 Belgian proton therapy specialist Ion Beam Applications (IBA) warned on Friday it expected to report a full-year operating loss due to delays in negotiations to sign proton therapy contracts.

05 Jan 2018

BRIEF-Ion Beam Applications Says Won't Meet Previous FY 2017 Revenue Guidance And Will Report A Negative Rebit

* IS FINALIZING LATE STAGE NEGOTIATIONS FOR CONTRACTS WITH AT LEAST FOUR PROTON THERAPY PROSPECTS THAT HAD BEEN EXPECTED TO BE SIGNED IN 2017

05 Jan 2018

BRIEF-Ion Beam Applications Signed Contract With Invap For Additional Gantry Treatment Room

* SIGNED NEW CONTRACT WITH INVAP FOR ADDITIONAL GANTRY TREATMENT ROOM AT CNEA

05 Jan 2018

BRIEF-IBA 9-month revenues at 217.3 million euros, down 3.6% ‍​

* 9M REVENUES TO 30 SEPTEMBER 2017 OF EUR 217.3 MILLION, DOWN 3.6% ‍​

16 Nov 2017

BRIEF-IBA signs global construction collaboration with Vinci

* VINCI CONSTRUCTION WILL LEAD IN THE DESIGN OF THE BUILDING AND RELATED TECHNICAL ELEMENTS‍​

10 Oct 2017

Belgium's IBA partners Vinci Construction to offer building support

Oct 10 Belgium's Ion Beam Applications (IBA) said on Tuesday it will collaborate with France's Vinci Construction to offer design and construction support to the proton therapy specialist's clients, a move designed to reduce project delays.

10 Oct 2017

BRIEF-IBA and Beaumont Hospital's Cancer Institute in Michigan announce partnership

* ‍IBA AND BEAUMONT HOSPITAL'S CANCER INSTITUTE IN ROYAL OAK, MICHIGAN ANNOUNCE PARTNERSHIP TO DEVELOP NEXT GENERATION PROTON THERAPY DELIVERY TECHNIQUE​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

25 Sep 2017

BRIEF- IBA and Elekta enter MOU regarding comprehensive partnership

* ANNOUNCED ON SATURDAY IBA AND ELEKTA ENTERED A MEMORANDUM OF UNDERSTANDING (MOU)REGARDING A COMPREHENSIVE PARTNERSHIP INCLUDING JOINT SOFTWARE DEVELOPMENT AND SALES TO ADVANCE PROTON THERAPY TREATMENTS Source text for Eikon:

25 Sep 2017

BRIEF-Elekta and IBA partner to advance proton therapy treatments

* Eleketa and Ion Beam Applications (IBA) enter an mou regarding a comprehensive partnership including joint software development and sales to advance proton therapy treatments Source text for Eikon: Further company coverage: (Stockholm Newsroom)

25 Sep 2017

MOVES-ICE appoints European futures and IBA heads

LONDON, Sept 6 (IFR) - Intercontinental Exchange has appointed Stuart Williams as president of ICE Futures Europe and Timothy Bowler as president of ICE Benchmark Administration (IBA), the unit that oversees Libor. Both appointments are effective from October.

06 Sep 2017

Earnings vs. Estimates